DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • India
  • /
  • Healthcare
Author Program NEWCreate Narrative
NH logo

Narayana Hrudayalaya Limited Stock Price

NSEI:NH Community·₹387.9b Market Cap
  • 3 Narratives written by author
  • 2 Comments on narratives written by author
  • 59 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

NH Share Price Performance

₹0
-1738.40 (-100.00%)
​
₹2,213.07
Fair Value
₹0
-1738.40 (-100.00%)
​
Price ₹0
Sat, 22 Aug 26
Fair Value₹2,213.07
Share Pricen/a

NH Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value ₹2.21k 15.5% undervalued intrinsic discount

Integrated Care And Oncology Expansion Will Shape India's Future

0users have liked this narrative
2users have commented on this narrative
33users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value ₹1.82k 2.9% overvalued intrinsic discount

Government Regulation And Evolving Care Models Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value ₹2.5k 25.2% undervalued intrinsic discount

India Urbanization And Digitalization Will Drive Premium Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
NH logo
Narayana Hrudayalaya
15.5% undervalued intrinsic discount

Integrated Care And Oncology Expansion Will Shape India's Future

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 22 Aug
Read Narrative
NH logo
Narayana Hrudayalaya
2.9% overvalued intrinsic discount
Updated

Government Regulation And Evolving Care Models Will Squeeze Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 5 Sep
Read Narrative
NH logo
Narayana Hrudayalaya
25.2% undervalued intrinsic discount

India Urbanization And Digitalization Will Drive Premium Healthcare Demand

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 2 May
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
NH logo

NH: Updated Margin Outlook And Board Meeting Plans Will Likely Support Fairly Valued Shares

Fair Value: ₹1.82k 2.9% overvalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
NH logo

NH: Future Returns Will Reflect Higher Margins And Upcoming Results Review

Fair Value: ₹2.21k 15.5% undervalued intrinsic discount
33 fair values setusers have set this as their fair value
2 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
NH logo

NH: Steady Assumptions And Upcoming Results Will Support Higher Future Share Value

Fair Value: ₹2.5k 25.2% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

High growth potential with mediocre balance sheet.

2 Risks
2 Rewards
View Full Analysis

Narayana Hrudayalaya Limited Key Details

₹90.7b

Revenue

₹54.7b

Cost of Revenue

₹36.1b

Gross Profit

₹27.9b

Other Expenses

₹8.2b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
40.44
39.76%
9.05%
129.0%
View Full Analysis

About NH

Founded
2000
Employees
11234
CEO
Emmanuel Rupert
WebsiteView website
www.narayanahealth.org

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, uro oncology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Recent NH News & Updates

User avatar
Narrative Update • Sep 05

NH: Updated Margin Outlook And Board Meeting Plans Will Likely Support Fairly Valued Shares

Analysts have lifted their price target for Narayana Hrudayalaya to ₹1,817 from ₹1,710, citing updated assumptions around revenue growth, profit margins and future P/E that collectively support a higher fair value estimate. What’s in the News for Narayana Hrudayalaya Narayana Hrudayalaya has scheduled a Board Meeting for Jul 31, 2026.
User avatar
Narrative Update • Aug 22

NH: Future Returns Will Reflect Higher Margins And Upcoming Results Review

Analysts have raised their price target on Narayana Hrudayalaya from about ₹2,122 to roughly ₹2,213, reflecting updated views that combine a slightly lower discount rate, revised revenue growth assumptions, higher projected profit margins, and a reduced future P/E multiple. What’s in the News for Narayana Hrudayalaya Narayana Hrudayalaya has scheduled a board meeting for 31 Jul 2026.
Analysis Article • Aug 05

Narayana Hrudayalaya Limited Just Missed Earnings - But Analysts Have Updated Their Models

Narayana Hrudayalaya Limited ( NSE:NH ) shareholders are probably feeling a little disappointed, since its shares fell...

Recent updates

No updates

Narayana Hrudayalaya Limited Competitors

APOLLOHOSP logo

Apollo Hospitals Enterprise

Symbol: NSEI:APOLLOHOSP
Market cap: ₹1.3t
543220 logo

Max Healthcare Institute

Symbol: BSE:543220
Market cap: ₹1.0t
MANIPALHOS logo

Manipal Health Enterprises

Symbol: NSEI:MANIPALHOS
Market cap: ₹964.5b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide